文献速递脑血管病外科神经重症

急性酒精中毒与酒精依赖对蛛网膜下腔出血后结局的影响

Impact of acute alcohol intoxication and alcohol dependence on outcomes after subarachnoid hemorrhage.
PubMed 文献 · Acta Neurochir (Wien) · 2025-08-27

这项基于人群的纵向研究利用TriNetX网络数据,分析酒精使用与蛛网膜下腔出血(SAH)后不良临床结局的关系。共识别216,894例非创伤性SAH患者,其中11,648例检测了酒精浓度、27,079例有酒精使用障碍。结果显示SAH当时血酒精浓度1-100 mg/dL及以上与30天死亡率降低相关,浓度201-300 mg/dL及以上保护作用更强;而酒精使用障碍则与死亡率风险升高相关(HR=1.175),且严重酒精依赖者风险更高(HR=1.139)。

要点

  • SAH当时血酒精浓度1-100 mg/dL及以上与30天死亡率降低相关,浓度更高保护更强。
  • 酒精使用障碍患者较无物质使用障碍者死亡风险升高(HR=1.175,95%CI 1.129-1.223)。
  • 严重酒精依赖者较轻中度使用障碍者死亡风险更高(HR=1.139,95%CI 1.128-1.150)。

核心结论

  • 非创伤性SAH患者中,SAH时血酒精浓度对30天死亡率有保护作用,且浓度越高保护越强。
  • paradoxically,酒精使用障碍导致临床结局恶化,包括死亡率升高,且酒精依赖严重程度对死亡率呈剂量依赖性效应。

研究设计与样本

  • 基于TriNetX研究网络的 population-based、纵向研究。
  • 比较酒精使用障碍(ICD-10编码F10)患者与无物质使用障碍(F10-F19均无)患者。
  • 在SAH当天检测血酒精浓度的患者中评估30天短期结局,采用倾向性评分匹配人口学、合并症、血细胞计数、物质使用及SAH严重程度后行Cox比例风险模型。

主要发现

  • 共识别216,894例非创伤性SAH患者,其中11,648例检测了酒精,27,079例有酒精使用障碍。
  • 与0 mg/dL相比,SAH时血酒精浓度1-100 mg/dL及以上与30天死亡率降低相关;201-300 mg/dL及以上较1-100 mg/dL进一步保护。
  • 酒精使用障碍患者较无物质使用障碍者(n=151,377)死亡风险升高(HR=1.175 [95%CI: 1.129, 1.223]; p<0.0001)。
  • 严重酒精依赖患者较轻中度使用障碍者死亡风险更高(HR=1.139 [95%CI: 1.128, 1.150] p<0.0001)。

临床怎么用

  • 对SAH患者应评估酒精使用障碍及依赖严重程度,以识别死亡风险较高的人群。
  • SAH时血酒精浓度与30天死亡率降低相关,但酒精使用障碍整体与结局恶化相关,临床需区分急性饮酒与慢性酒精使用障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-traumatic subarachnoid hemorrhage (SAH) is most commonly caused by a ruptured aneurysm. Risk factors for rupture include hypertension, smoking, and substance use, but the relationship between alcohol use and clinical outcomes after SAH is poorly understood. The objective of this population-based, longitudinal, study is to characterize the relationships between alcohol use, alcohol dependence, and adverse clinical outcomes following SAH. METHODS: Patients with alcohol use disorder (International Classification of Disease 10th Revision Diagnostic Code F10) in the TriNetX Research Network were compared to patients with no substance use disorders (None of F10-F19). Short-term (30-day) outcomes were assessed among patients with blood alcohol concentrations tested on the day of SAH. Outcome frequencies and Cox proportional hazard models used propensity score matching on demographics, comorbidities, blood counts, substance use, and SAH severity. RESULTS: We identified 216,894 patients with non-traumatic SAH. Of these, 11,648 were tested for alcohol and 27,079 patients had alcohol use disorder. Blood alcohol levels of 1-100 mg/dL and above at the time of SAH were associated with decreased 30-day mortality in acute alcohol use compared to 0 mg/dL, and alcohol concentrations of 201-300 mg/dL and higher were further protective relative to 1-100 mg/dL. Patients with alcohol use disorder exhibited an increased hazard of mortality (HR = 1.175 [95% CI: 1.129, 1.223]; p < 0.0001) compared to patients with no substance use disorders (n = 151,377). Patients with severe alcohol dependence had an even higher hazard of mortality compared to patients with mild/moderate use disorder (HR = 1.139 [1.128, 1.150] p < 0.0001). CONCLUSIONS: In patients with non-traumatic SAH, alcohol in the blood at the time of SAH is protective against 30-day mortality, and increased alcohol concentration adds increased protection. Paradoxically, alcohol use disorder leads to a worsening of clinical outcomes, including mortality. There appears to be a significant dose-dependent effect of severity of alcohol dependence on mortality.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Thorman IB, Jain A, Mashiach E, et al. Impact of acute alcohol intoxication and alcohol dependence on outcomes after subarachnoid hemorrhage. Acta Neurochir (Wien). 2025. PMID: 40864201. doi:10.1007/s00701-025-06639-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。